We present data showing that SLC25A21 expression was downregulated in KRAS-mutant CRC tissues and cell lines and that SLC25A21 downregulation was correlated with poor survival of patients with KRAS-mutant CRC. The gene discussed is KRAS; the disease is colorectal carcinoma.